Effects of Telmisartan and Candesartan on the Metabolism of Lipids and Glucose in Kidney Transplant Patients: A Prospective, Randomized Crossover Study

BACKGROUND: The risk of cardiovascular events remains after kidney transplantation (KT). Abnormal glucose metabolism and hyperlipidemia contribute partly to this risk. Among angiotensin II type-1 receptor blockers, telmisartan alone has been shown to ameliorate these effects on glucose and lipid met...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Transplant Direct
Päätekijät: Miura, Yoshifumi, Noguchi, Hiroshi, Okabe, Yasuhiro, Masutani, Kosuke, Tokunaga, Shoji, Nakamura, Masafumi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Lippincott Williams & Wilkins 2019
Aiheet:
Kidney Transplantation
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6415969/
https://ncbi.nlm.nih.gov/pubmed/30882027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000861
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia